kreuzkirche dresden: vesper

The first major growth driver for AstraZeneca is the company's oncology portfolio . The firm has a market capitalization of $127.08 billion, a PE ratio of 50.44, a PEG ratio of 1.18 and a beta of 0.55. AstraZeneca has a 12 month low of $36.15 and a 12 month high of $64.94. The P/E ratio of AstraZeneca is 50.70, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 39.52. A PEG ratio is a valuation analysis that compares the price earnings ratio (PE) to the EPS growth rate of a company. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. AstraZeneca's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.039. The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company’s market … The firm’s 50-day moving average price is $50.28 … Valuation Ratios. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.76 and a current ratio of 0.96. Find out all the key statistics for Astrazeneca PLC (AZN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. AZN's PEG comes from its forward price to earnings ratio being divided by its growth rate. This is one of the best ways to identify relative value, especially in companies that are growing faster than the general market and whose price earnings multiples seemed quite high when compared to other stocks. AstraZeneca's PEG ratio. The business has a 50 day simple moving average of $50.41 and a two-hundred day simple moving average of $51.98. The Relative Strength Index (RSI, 14) currently prints 43.24, while 7-day volatility ratio is 1.6% and 1.75% in … AstraZeneca has a PEG Ratio of 1.18. The stock has a market cap of $135.67 billion, a price-to-earnings ratio of 53.84, a PEG ratio of 1.18 and a beta of 0.55. Price to Earnings Growth Ratio. The business has a 50 day simple moving average of $50.93 and a 200 day simple moving average of $52.33. The company has a market capitalization of $131.23 billion, a price-to-earnings ratio of 52.08, a PEG ratio of 1.18 and a beta of 0.55. Price to Earnings Ratio vs. Sector. The stock has a 50-day moving average of $50.78 and a 200 day moving average of $52.50. PEG Ratios above 1 indicate that a company could be overvalued. The technical evaluation for the stock shows the PEG ratio is 2.05, with AZN’s current price about -2.12% and -4.09% off the 20-day and 50-day simple moving averages respectively. A low ratio … AstraZeneca's PEG ratio is 1.14. The stock has a market capitalization of $130.73 billion, a P/E ratio of 51.89, a PEG ratio of 1.18 and a beta of 0.55. AstraZeneca has a … The trailing PE ratio is 53.56 and the forward PE ratio is 20.24. After two decades of going sideways, AstraZeneca has two big catalysts in its sails and a PEG ratio just above 1. AstraZeneca PLC has a twelve month low of $36.15 and a twelve month high of $64.94.

Chemnitz Verliert Einwohner, Red Dead Redemption 2 Laufbursche, Zitat Licht Im Herzen, Wie Viel Verdient Eine Profi Handballerin, Sterne Basteln Ohne Kleben Youtube, Bilder Freude Kostenlos, Kuchen Ohne Ei Rezeptwelt, Saftiger Marmorkuchen Mit öl Und Milch, Aktuelles Aus Kassel,

Geschrieben am Februar 20th, 2021